Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04523 |
| Species: | Homo sapiens |
| Position : | chr8:81274400-81275960 |
| Year: | 2015 |
| Title: | Long-Range Modulation of PAG1 Expression by 8q21 Allergy Risk Variants. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | chronic myeloid leukemia |
| PMID: | 26211970 |
| MONDO: | MONDO:0011996 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | K-562 |
| CVCL ID: | CVCL_0004 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay; Chromatin interaction assay; Disease-variant functional analysis |
| High Throughput Method: | Capture-C; GWAS |
| Low Throughput Method: | Luciferase Reporter Assay; Allele-specific reporter assay |
| Target gene : | PAG1 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|